Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Study ID: NCT06161532
Start Date: 2024-08-01
End Date: 2028-11-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Sacituzumab govitesan

Atezolizumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Study ID: NCT06239194
Start Date: 2024-06-12
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

115

Intervention / Treatment

MDX2001

Sponsor

ModeX Therapeutics, An OPKO Health Company

Source: clinicaltrials.gov

Share:
Add to list

A Study of NB003 in Patients With Advanced Malignancies

Study ID: NCT04936178
Start Date: 2021-08-06
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

258

Intervention / Treatment

NB003 tablets

Sponsor

Ningbo Newbay Technology Development Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Study ID: NCT07115043
Start Date: 2025-07-29
End Date: 2029-10-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

AZD6750

rilvegostomig

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

Innovating CBT-I for Cancer Survivors: An Optimization Trial

Study ID: NCT06181643
Start Date: 2024-09-06
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Survivorship Sleep Program with Individual Delivery + No Booster Sessions

Survivorship Sleep Program with Group Delivery + No Booster Sessions

Survivorship Sleep Program with Individual Delivery + 3 Booster Sessions

Survivorship Sleep Program with Group Delivery + 3 Booster Sessions

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Study ID: NCT06146725
Start Date: 2023-01-01
End Date: 2029-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

564

Intervention / Treatment

Tumor resection

Tumor biopsy

Sponsor

Jasper Gerritsen

Source: clinicaltrials.gov

Share:
Add to list

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Study ID: NCT04670874
Start Date: 2023-08-17
End Date: 2034-01-24
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1250

Intervention / Treatment

Quality-of-Life Assessment

Administration Questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Study ID: NCT04689048
Start Date: 2022-04-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

18F fluciclovine

Sponsor

Baptist Health South Florida

Source: clinicaltrials.gov

Share:
Add to list

Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

Study ID: NCT01608152
Start Date: 2013-02-20
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Focus Group

Internet-Based Intervention

Interview

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer

Study ID: NCT04656678
Start Date: 2020-11-25
End Date: 2025-10-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance

Sponsor

Northwell Health

Source: clinicaltrials.gov

Share:
Add to list